• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Terminalia ferdinandiana 果实和叶提取物抑制耐甲氧西林金黄色葡萄球菌生长。

Terminalia ferdinandiana Fruit and Leaf Extracts Inhibit Methicillin-Resistant Staphylococcus aureus Growth.

机构信息

School of Pharmacy and Pharmacology, Gold Coast Campus, Griffith University, Australia.

Menzies Health Institute Queensland, Quality Use of Medicines Network, Australia.

出版信息

Planta Med. 2019 Nov;85(16):1253-1262. doi: 10.1055/a-1013-0434. Epub 2019 Oct 9.

DOI:10.1055/a-1013-0434
PMID:31597166
Abstract

The development of multiple antibiotic-resistant bacteria has vastly depleted our repertoire of effective antibiotic chemotherapies. The development of multi--lactam-resistant strains are particularly concerning due to our previous reliance on this class of antibiotics because of their initial efficacy and broad-spectrum activity. With increases in extended-spectrum -lactam-resistance and an expanded resistance to other classes of antibiotics, there is an urgent need for the development of effective new antibiotic therapies. is an endemic Australian plant known for its high antioxidant and tannin contents. fruit and leaf extracts have strong antibacterial activity against a wide variety of bacterial pathogens. However, extracts have not been tested against ESBL and MRSA antibiotic-resistant pathogens. An objective of this study was to screen fruit and leaf extracts for bacterial growth inhibitory activity by disc diffusion assay against -lactam-sensitive and -resistant strains and against methicillin-sensitive and -resistant . The minimum inhibitory concentration (MIC) was quantified by liquid dilution techniques. The fruit methanolic extract, as well as the methanolic, aqueous, and ethyl acetate leaf extracts strongly inhibited the growth of the MRSA, with MICs as low as 223 µg/mL. In contrast, the extracts were ineffective inhibitors of ESBL growth. Metabolomic fingerprint analysis identified a diversity and relative abundance of tannins, flavonoids, and terpenoids, several of which have been reported to inhibit MRSA growth in isolation. All extracts were nontoxic in the nauplii and HDF toxicity assays, further indicating their potential for medicinal use.

摘要

多种抗生素耐药菌的发展大大减少了我们有效的抗生素化疗药物库。由于我们以前依赖于这类抗生素,因为它们最初的疗效和广谱活性,因此多-内酰胺耐药株的发展尤其令人担忧。随着广谱-内酰胺耐药性的增加和对其他类抗生素的耐药性的扩大,迫切需要开发有效的新型抗生素治疗方法。是一种澳大利亚特有的植物,以其高抗氧化剂和单宁含量而闻名。 水果和叶提取物对多种细菌病原体具有很强的抗菌活性。然而,尚未对 ESBL 和耐甲氧西林金黄色葡萄球菌(MRSA)抗生素耐药病原体进行 提取物测试。本研究的目的之一是通过圆盘扩散法筛选水果和叶提取物对 -内酰胺敏感和 -耐药 株以及对甲氧西林敏感和 -耐药 的细菌生长抑制活性。通过液体稀释技术定量最小抑菌浓度(MIC)。水果甲醇提取物以及甲醇、水和乙酸乙酯叶提取物强烈抑制了 MRSA 的生长,其 MIC 低至 223 µg/mL。相比之下,提取物对 ESBL 生长没有抑制作用。代谢组指纹分析确定了多种单宁、类黄酮和萜类化合物的多样性和相对丰度,其中一些已被报道可单独抑制 MRSA 的生长。所有提取物在 水蚤和 HDF 毒性试验中均无毒性,进一步表明它们具有药用潜力。

相似文献

1
Terminalia ferdinandiana Fruit and Leaf Extracts Inhibit Methicillin-Resistant Staphylococcus aureus Growth.Terminalia ferdinandiana 果实和叶提取物抑制耐甲氧西林金黄色葡萄球菌生长。
Planta Med. 2019 Nov;85(16):1253-1262. doi: 10.1055/a-1013-0434. Epub 2019 Oct 9.
2
Terminalia ferdinandiana Exell. Extracts inhibit the growth of body odour-forming bacteria.费氏榄仁提取物可抑制产生体臭的细菌生长。
Int J Cosmet Sci. 2017 Oct;39(5):500-510. doi: 10.1111/ics.12403. Epub 2017 Jul 5.
3
Terminalia ferdinandiana Exell. Fruit and Leaf Extracts Inhibit Proliferation and Induce Apoptosis in Selected Human Cancer Cell Lines.费氏榄仁果实和叶片提取物对特定人类癌细胞系的增殖具有抑制作用并可诱导其凋亡。
Nutr Cancer. 2018 May-Jun;70(4):579-593. doi: 10.1080/01635581.2018.1460680. Epub 2018 Apr 11.
4
Terminalia bellirica fruit extracts: in-vitro antibacterial activity against selected multidrug-resistant bacteria, radical scavenging activity and cytotoxicity study on BHK-21 cells.诃子果实提取物:对选定的多重耐药菌的体外抗菌活性、自由基清除活性和 BHK-21 细胞的细胞毒性研究。
BMC Complement Altern Med. 2018 Dec 7;18(1):325. doi: 10.1186/s12906-018-2382-7.
5
Selected Australian Species Extracts Inhibit β-Lactam Drug-Resistant Bacteria Growth and Potentiate the Activity of Conventional Antibiotics: Bioactivities and Phytochemistry.精选澳大利亚物种提取物可抑制β-内酰胺类耐药菌生长并增强传统抗生素活性:生物活性与植物化学
Microorganisms. 2024 Feb 29;12(3):498. doi: 10.3390/microorganisms12030498.
6
Inhibition of the growth of human dermatophytic pathogens by selected australian and asian plants traditionally used to treat fungal infections.某些传统用于治疗真菌感染的澳大利亚和亚洲植物对人体皮肤真菌病原体生长的抑制作用。
J Mycol Med. 2019 Dec;29(4):331-344. doi: 10.1016/j.mycmed.2019.05.003. Epub 2019 Jun 24.
7
Terminalia ferdinandiana extracts as inhibitors of Giardia duodenalis proliferation: a new treatment for giardiasis.诃子提取物作为十二指肠贾第虫增殖的抑制剂:一种治疗贾第虫病的新方法。
Parasitol Res. 2015 Jul;114(7):2611-20. doi: 10.1007/s00436-015-4465-4. Epub 2015 Apr 16.
8
Terminalia ferdinandiana Exell: Extracts inhibit Shewanella spp. growth and prevent fish spoilage.Terminalia ferdinandiana Exell:提取物抑制希瓦氏菌属的生长并防止鱼类腐败。
Food Microbiol. 2019 Apr;78:114-122. doi: 10.1016/j.fm.2018.10.006. Epub 2018 Oct 18.
9
Hydrolysable tannins in Terminalia ferdinandiana Exell fruit powder and comparison of their functional properties from different solvent extracts.没食子酸单宁在Terminalia ferdinandiana Exell 果干粉中的水解及其不同溶剂提取物功能性质的比较。
Food Chem. 2021 Oct 1;358:129833. doi: 10.1016/j.foodchem.2021.129833. Epub 2021 Apr 20.
10
Bioactive compounds sourced from Terminalia spp. in bacterial malodour prevention: an effective alternative to chemical additives.来源于诃子属植物的生物活性化合物可预防细菌异味:一种替代化学添加剂的有效方法。
Int J Cosmet Sci. 2019 Oct;41(5):496-508. doi: 10.1111/ics.12567.

引用本文的文献

1
Nutritional and Functional Properties of Fruits Wild Harvested from Western Australia.从西澳大利亚野生采摘的水果的营养和功能特性
Foods. 2024 Sep 12;13(18):2888. doi: 10.3390/foods13182888.
2
Terminalia ferdinandiana Exell. extracts reduce pro-inflammatory cytokine and PGE secretion, decrease COX-2 expression and down-regulate cytosolic NF-κB levels.Terminalia ferdinandiana Exell. 提取物可减少促炎细胞因子和 PGE 的分泌,降低 COX-2 的表达,并下调细胞质 NF-κB 水平。
Inflammopharmacology. 2024 Jun;32(3):1839-1853. doi: 10.1007/s10787-024-01462-7. Epub 2024 Apr 6.
3
Selected Australian Species Extracts Inhibit β-Lactam Drug-Resistant Bacteria Growth and Potentiate the Activity of Conventional Antibiotics: Bioactivities and Phytochemistry.
精选澳大利亚物种提取物可抑制β-内酰胺类耐药菌生长并增强传统抗生素活性:生物活性与植物化学
Microorganisms. 2024 Feb 29;12(3):498. doi: 10.3390/microorganisms12030498.
4
Phytochemical Evaluation of DC. Radlk. Extracts with Antibacterial and Antibiotic Potentiation Activities against Selected β-Lactam Drug-Resistant Bacteria.植物化学成分评估:DC. Radlk. 提取物具有针对选定的β-内酰胺类药物耐药菌的抗菌和抗生素增效活性。
Molecules. 2024 Mar 20;29(6):1385. doi: 10.3390/molecules29061385.
5
A Review of Phytochemicals and Bioactive Properties in the Proteaceae Family: A Promising Source of Functional Food.山龙眼科植物中的植物化学物质和生物活性特性综述:功能性食品的一个有前景的来源。
Antioxidants (Basel). 2023 Nov 1;12(11):1952. doi: 10.3390/antiox12111952.
6
Phytochemicals, Antioxidant Activities, and Toxicological Screening of Native Australian Fruits Using Zebrafish Embryonic Model.利用斑马鱼胚胎模型对澳大利亚本土水果进行植物化学物质、抗氧化活性及毒理学筛选
Foods. 2022 Dec 14;11(24):4038. doi: 10.3390/foods11244038.
7
Hydrolysable tannins, physicochemical properties, and antioxidant property of wild-harvested (exell) fruit at different maturity stages.不同成熟阶段野生采摘(埃塞尔)果实的可水解单宁、理化性质及抗氧化性能
Front Nutr. 2022 Jul 29;9:961679. doi: 10.3389/fnut.2022.961679. eCollection 2022.
8
Antioxidants of Fruit Extracts as Antimicrobial Agents against Pathogenic Bacteria.水果提取物中的抗氧化剂作为抗病原菌的抗菌剂
Antioxidants (Basel). 2022 Mar 21;11(3):602. doi: 10.3390/antiox11030602.
9
Comparison of the antibacterial activity of Australian Terminalia spp. extracts against Klebsiella pneumoniae: a potential treatment for ankylosing spondylitis.比较澳大利亚特瑞里亚属植物提取物对肺炎克雷伯菌的抗菌活性:一种治疗强直性脊柱炎的潜在方法。
Inflammopharmacology. 2022 Feb;30(1):207-223. doi: 10.1007/s10787-021-00914-8. Epub 2022 Jan 6.
10
An assessment of the growth inhibition profiles of L. extracts against and spp.对L.提取物针对……和……物种的生长抑制谱的评估
J Tradit Complement Med. 2021 Apr 1;11(5):457-465. doi: 10.1016/j.jtcme.2021.03.002. eCollection 2021 Sep.